한글목차

여드름 치료제 동향 및 전망

세계 여드름 치료제 시장은 2024년부터 2030년까지 연평균 4.2%의 성장률을 보일 것으로 예상됩니다. 이 시장의 주요 촉진요인은 생활 습관의 변화와 피부 질환의 증가입니다. 세계 여드름 치료제 시장은 국소, 경구, 주사제 시장에서의 기회로 인해 미래가 유망합니다.

부문별 여드름 치료제

본 조사에서는 세계 여드름 치료제 시장 예측을 유형별, 치료군별, 투여 방법별, 지역별 예측을 제시합니다.

여드름 치료제 시장 인사이트

Lucintel은 세균 감염 사례의 증가로 인해 염증성 질환이 예측 기간 동안 가장 큰 부문으로 남을 것으로 예상하고 있습니다.

이 시장에서 국소 의약품은 여전히 가장 큰 부문입니다.

북미는 라이프스타일의 변화와 질병 발병률 증가로 인해 예측 기간 동안 가장 큰 지역으로 남을 것입니다.

자주 묻는 질문

Q1. 시장 성장 예측은?

A1. 세계 여드름 치료제 시장은 2024년부터 2030년까지 연평균 4.2%의 성장률을 보일 것으로 예상됩니다.

Q2. 시장 성장에 영향을 미치는 주요 촉진요인은?

A2. 이 시장의 주요 촉진요인은 생활 습관의 변화와 피부 질환의 증가입니다.

Q3. 시장의 주요 부문은?

A3. 여드름 치료제 시장의 미래는 국소약, 경구약, 주사제 시장에서 기회가 있고 유망합니다.

Q4. 시장의 주요 기업은?

A4. 주요 여드름 치료제 기업은 다음과 같습니다.

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5. 향후 가장 큰 시장 부문은?

A5. Lucintel은 예측 기간 동안 염증성 질환이 세균 감염 사례의 증가로 인해 염증성 질환이 가장 큰 부문으로 남을 것으로 예측합니다.

Q6. 시장에서 향후 5년간 가장 큰 시장이 될 것으로 예상되는 지역은?

A6. 라이프스타일의 변화와 질병 이환율 증가로 인해 예측 기간 동안 북미는 여전히 가장 큰 지역입니다.

Q7. 보고서 사용자 정의가 가능합니까?

A7. 예, Lucintel은 추가 비용없이 10%의 사용자 정의를 제공합니다.

목차

제1장 주요 요약

제2장 세계의 여드름 치료제 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 여드름 치료제 시장 동향(2018-2023년)과 예측(2024-2030년)
• 유형별 세계의 여드름 치료제 시장
  • 면포성
  • 염증성
  • 낭포성
  • 수술후/창상
• 치료 클래스별 세계의 여드름 치료제 시장
  • 레티노이드
  • 항생제
  • 호르몬제
  • 배합
  • 기타
• 투여 방법별 세계의 여드름 치료제 시장
  • 국소
  • 경구
  • 주사

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 세계의 여드름 치료제 시장
• 북미의 여드름 치료제 시장
• 유럽의 여드름 치료제 시장
• 아시아태평양의 여드름 치료제 시장
• 기타 지역의 여드름 치료제 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
• 세계의 여드름 치료제 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 여드름 치료제 시장 생산능력 확대
  • 세계의 여드름 치료제 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

영문목차

Acne Drug Trends and Forecast

The future of the global acne drug market looks promising with opportunities in the topical, oral, and injectable markets. The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030. The major drivers for this market are changing lifestyle and increasing dermatological diseases.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Acne Drug by Segment

The study includes a forecast for the global acne drug by type, therapeutic class, mode of administration, and region.

Acne Drug Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Comedonal
• Inflammatory
• Cystic
• Postsurgical/Wound

Acne Drug Market by Therapeutic Class [Shipment Analysis by Value from 2018 to 2030]:

• Retinoid
• Antibiotic
• Hormonal Agent
• Combination
• Others

Acne Drug Market by Mode of Administration [Shipment Analysis by Value from 2018 to 2030]:

• Topical
• Oral
• Injectable

Acne Drug Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Acne Drug Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies acne drug companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the acne drug companies profiled in this report include-

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Acne Drug Market Insights

Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Within this market, topical will remain the largest segment.

North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Features of the Global Acne Drug Market

Market Size Estimates: Acne drug market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Acne drug market size by type, therapeutic class, mode of administration, and region in terms of value ($B).

Regional Analysis: Acne drug market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, therapeutic classes, mode of administration, and regions for the acne drug market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the acne drug market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for acne drug market?

Answer: The global acne drug market is expected to grow with a CAGR of 4.2% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the acne drug market?

Answer: The major drivers for this market are changing lifestyle and increasing dermatological diseases.

Q3. What are the major segments for acne drug market?

Answer: The future of the acne drug market looks promising with opportunities in the topical, oral, and injectable markets.

Q4. Who are the key acne drug market companies?

Answer: Some of the key acne drug companies are as follows:

• Allergan
• Bayer
• Galderma
• Stiefel
• Valeant

Q5. Which acne drug market segment will be the largest in future?

Answer: Lucintel forecasts that inflammatory will remain the largest segment over the forecast period due to increasing cases of bacterial infections.

Q6. In acne drug market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to changing lifestyles and increasing disease incidence.

Q.7 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the acne drug market by type (comedonal, inflammatory, cystic, and postsurgical/wound), therapeutic class (retinoid, antibiotic, hormonal agent, combination, and others), mode of administration (topical, oral, and injectable), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Acne Drug Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Acne Drug Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Acne Drug Market by Type
  • 3.3.1: Comedonal
  • 3.3.2: Inflammatory
  • 3.3.3: Cystic
  • 3.3.4: Postsurgical/Wound
• 3.4: Global Acne Drug Market by Therapeutic Class
  • 3.4.1: Retinoid
  • 3.4.2: Antibiotic
  • 3.4.3: Hormonal Agent
  • 3.4.4: Combination
  • 3.4.5: Others
• 3.5: Global Acne Drug Market by Mode of Administration
  • 3.5.1: Topical
  • 3.5.2: Oral
  • 3.5.3: Injectable

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Acne Drug Market by Region
• 4.2: North American Acne Drug Market
  • 4.2.1: North American Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.2.2: North American Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.3: European Acne Drug Market
  • 4.3.1: European Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.3.2: European Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.4: APAC Acne Drug Market
  • 4.4.1: APAC Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.4.2: APAC Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable
• 4.5: ROW Acne Drug Market
  • 4.5.1: ROW Acne Drug Market by Type: Comedonal, Inflammatory, Cystic, and Postsurgical/Wound
  • 4.5.2: ROW Acne Drug Market by Mode of Administration: Topical, Oral, and Injectable

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Acne Drug Market by Type
  • 6.1.2: Growth Opportunities for the Global Acne Drug Market by Therapeutic Class
  • 6.1.3: Growth Opportunities for the Global Acne Drug Market by Mode of Administration
  • 6.1.4: Growth Opportunities for the Global Acne Drug Market by Region
• 6.2: Emerging Trends in the Global Acne Drug Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Acne Drug Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Acne Drug Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Allergan
• 7.2: Bayer
• 7.3: Galderma
• 7.4: Stiefel
• 7.5: Valeant